Attributes | Values |
---|
rdf:type
| |
Description
| - The aim of this study was to investigate the prognostic significance of fourteen anticancer drug-relevant solute carrier transporters (SLCs) in pancreatic cancer in the context of clinical-pathological characteristics and the KRAS mutation status of tumors. Tumors and non-neoplastic pancreatic tissues were obtained from 32 histologically verified patients with pancreatic ductal adenocarcinoma. The transcript profile of SLCs was assessed using quantitative real-time PCR. KRAS mutations in exon 2 were assessed by high-resolution melting analysis and confirmed by sequencing.
- The aim of this study was to investigate the prognostic significance of fourteen anticancer drug-relevant solute carrier transporters (SLCs) in pancreatic cancer in the context of clinical-pathological characteristics and the KRAS mutation status of tumors. Tumors and non-neoplastic pancreatic tissues were obtained from 32 histologically verified patients with pancreatic ductal adenocarcinoma. The transcript profile of SLCs was assessed using quantitative real-time PCR. KRAS mutations in exon 2 were assessed by high-resolution melting analysis and confirmed by sequencing. (en)
|
Title
| - The associastion between the expression of solute carrier transporters and the prognosis of pancreatic cancer
- The associastion between the expression of solute carrier transporters and the prognosis of pancreatic cancer (en)
|
skos:prefLabel
| - The associastion between the expression of solute carrier transporters and the prognosis of pancreatic cancer
- The associastion between the expression of solute carrier transporters and the prognosis of pancreatic cancer (en)
|
skos:notation
| - RIV/61989592:15110/13:33145222!RIV14-MSM-15110___
|
http://linked.open...avai/predkladatel
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15110/13:33145222
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - KRAS; Survival; Gene expression; SLC transporters; Pancreatic cancer (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Cancer Chemotherapy and Pharmacology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Honsová, Eva
- Hlavsa, Jan
- Kala, Zdeněk
- Kočík, Matěj
- Melichar, Bohuslav
- Oliverius, Martin
- Souček, Pavel
- Brynychová, Veronika
- Hlaváč, Viktor
- Mazanec, Jan
- Mohelníková Duchoňová, Beatrice
|
issn
| |
number of pages
| |
http://bibframe.org/vocab/doi
| - 10.1007/s00280-013-2246-2
|
http://localhost/t...ganizacniJednotka
| |